Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-05-30

Clinical Trial Update: Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease [NA]

View source ↗

Summary

A clinical trial update examines whether anti-TNF antibodies alter T-lymphocyte and macrophage interactions in Crohn's disease. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Crohn Disease | NA | Status: TERMINATED